chlorhexidine and voriconazole

chlorhexidine has been researched along with voriconazole in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.67)29.6817
2010's7 (46.67)24.3611
2020's7 (46.67)2.80

Authors

AuthorsStudies
Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S1
Fernandes, M; Lakshmipathy, M; Shah, SG; Sharma, S1
Arnalich-Montiel, F; López-Arencibia, A; Lorenzo-Morales, J; Martín-Navarro, CM; Piñero, JE; Valladares, B1
Abdel Aziz, S; Kowalski, RP; Nau, AC; Raju, LV; Romanowski, EG; Shanks, RM1
Cabello-Vílchez, AM; López-Arencibia, A; Lorenzo-Morales, J; Martín-Navarro, CM; Piñero, JE; Reyes-Batlle, M; Sifaoui, I; Valladares, B1
Dorta-Gorrín, A; López-Arencibia, A; Lorenzo-Morales, J; Martín-Barrera, F; Martín-Navarro, CM; Martínez-Carretero, E; Piñero, JE; Reyes-Batlle, M; Rocha-Cabrera, P; Sifaoui, I; Valladares, B1
Alcántara-Castro, M; Castelan-Ramírez, I; Flores-Alvarado, V; González-Robles, A; Hernández-Martínez, D; Hernández-Olmos, P; Lorenzo-Morales, J; Omaña-Molina, M; Ramírez-Flores, E; Reyes-Batlle, M; Salazar-Villatoro, L; Servín-Flores, C; Vanzzini-Zago, V1
Castelan-Ramírez, I; Hernández-Martínez, D; Hernández-Olmos, P; Lorenzo-Morales, J; Omaña-Molina, M; Piñero, JE; Ramírez-Flores, E; Reyes-Batlle, M; Sifaoui, I; Vanzzini-Zago, V1
Bagga, B; Garg, P; Gour, RPS; Joseph, J; M Rathi, V; Mohamed, A; Sharma, S1
Jiang, T; Sun, Y; Tan, J; Tang, J; Wu, Z; Yang, L1
Arunga, S; Burton, MJ; Chaudhary, P; Das Sanyam, S; Hoffman, JJ; Hu, V; Leck, A; Macleod, D; Matayan, E; Roshan, A; Singh, SK; Weiss, HA; Yadav, R1
Bagga, B; Garg, P; Gour, RPS; Joseph, J; Mohamed, A; Rathi, V; Sharma, S1
Iovieno, A; Yeung, SN1
Arunga, S; Burton, MJ; Chaudhary, P; Hoffman, JJ; Hu, VH; Leck, A; Macleod, D; Mishra, SK; Roshan, A; Sanyam, SD; Singh, SK; Yadav, R1
Cevallos, V; Elakkiya, S; Kamal, FS; Keenan, JD; Lietman, TM; Prajna, L; Prajna, NV; Rajaraman, R; Richardson, QR; Seitzman, GD; Talbott, M1

Trials

3 trial(s) available for chlorhexidine and voriconazole

ArticleYear
A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba k
    Eye (London, England), 2021, Volume: 35, Issue:5

    Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Humans; Ophthalmic Solutions; Prospective Studies; Voriconazole

2021
Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial.
    BMJ open, 2020, 09-30, Volume: 10, Issue:9

    Topics: Administration, Topical; Adult; Chlorhexidine; Humans; London; Natamycin; Nepal; Treatment Outcome; Voriconazole

2020
Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
    Ophthalmology, 2022, Volume: 129, Issue:5

    Topics: Adult; Antifungal Agents; Chlorhexidine; Corneal Ulcer; Eye Infections, Fungal; Fungi; Humans; Keratitis; Mycoses; Natamycin; Nepal; Treatment Outcome; Voriconazole

2022

Other Studies

12 other study(ies) available for chlorhexidine and voriconazole

ArticleYear
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole

2006
Rapid detection of Acanthamoeba cysts in frozen sections of corneal scrapings with Fungiflora Y.
    The British journal of ophthalmology, 2010, Volume: 94, Issue:11

    Topics: Acanthamoeba; Acanthamoeba Keratitis; Anti-Infective Agents, Local; Chlorhexidine; Coloring Agents; Corneal Diseases; Epithelium, Corneal; Eye Infections, Parasitic; Frozen Sections; Humans; Organic Chemicals; Pyrimidines; Triazoles; Voriconazole

2010
Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:9

    Topics: Acanthamoeba castellanii; Amebicides; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aza Compounds; Chlorhexidine; Colorimetry; Drug Combinations; Fluoroquinolones; HeLa Cells; Humans; Macrophages; Mice; Moxifloxacin; Ophthalmic Solutions; Parasitic Sensitivity Tests; Pyrimidines; Quinolines; Triazoles; Voriconazole

2013
Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
    JAMA ophthalmology, 2013, Volume: 131, Issue:11

    Topics: Acanthamoeba; Acanthamoeba Keratitis; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Disinfectants; Humans; Parasitic Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2013
Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.
    Parasitology research, 2014, Volume: 113, Issue:2

    Topics: Acanthamoeba; Amebiasis; Amebicides; Chlorhexidine; Humans; Parasitic Sensitivity Tests; Peru; Pyrimidines; Triazoles; Voriconazole

2014
Detection of Acanthamoeba on the ocular surface in a Spanish population using the Schirmer strip test: pathogenic potential, molecular classification and evaluation of the sensitivity to chlorhexidine and voriconazole of the isolated Acanthamoeba strains.
    Journal of medical microbiology, 2015, Volume: 64, Issue:8

    Topics: Acanthamoeba; Antiprotozoal Agents; Cell Survival; Chlorhexidine; Cluster Analysis; DNA, Protozoan; Eye; Female; Genotype; Healthy Volunteers; Hot Temperature; Humans; Male; Middle Aged; Molecular Sequence Data; Osmotic Pressure; Parasitic Sensitivity Tests; Sequence Analysis, DNA; Sequence Homology; Spain; Virulence; Voriconazole

2015
Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
    Experimental parasitology, 2019, Volume: 196

    Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Chlorhexidine; Contact Lenses; Dogs; Female; Humans; Inhibitory Concentration 50; Itraconazole; Madin Darby Canine Kidney Cells; Mexico; Mice; Mice, Inbred BALB C; Mydriatics; Netilmicin; Parasitic Sensitivity Tests; Phenylephrine; Tropicamide; Voriconazole

2019
Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
    Experimental parasitology, 2019, Volume: 197

    Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebiasis; Anti-Infective Agents; Chlorhexidine; Contact Lenses; Corneal Ulcer; DNA, Protozoan; Genotype; Humans; Inhibitory Concentration 50; Itraconazole; Mexico; Soil; Voriconazole

2019
The combined utilization of Chlorhexidine and Voriconazole or Natamycin to combat Fusarium infections.
    BMC microbiology, 2020, 09-05, Volume: 20, Issue:1

    Topics: Animals; Antifungal Agents; Chlorhexidine; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fusariosis; Fusarium; Humans; Larva; Microbial Sensitivity Tests; Moths; Natamycin; Voriconazole

2020
Response to 'Comment on: 'A randomized masked pilot clinical trial to compare the efficacy of topical 1% Voriconazole ophthalmic solution as monotherapy to combination therapy with topical 0.02% Polyhexamethylene biguanide and 0.02% Chlorhexidine in the t
    Eye (London, England), 2022, Volume: 36, Issue:2

    Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Humans; Ophthalmic Solutions; Voriconazole

2022
Comment on: 'A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of A
    Eye (London, England), 2022, Volume: 36, Issue:2

    Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Humans; Ophthalmic Solutions; Voriconazole

2022
Antiamoebic Susceptibility in Acanthamoeba Keratitis: Comparison of Isolates From South India and Northern California.
    Cornea, 2023, Jan-01, Volume: 42, Issue:1

    Topics: Acanthamoeba; Acanthamoeba Keratitis; California; Chlorhexidine; Humans; Voriconazole

2023